The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 12, Issue 1, 2010, Pages 82-87

  Luzio, S D ^a   Dunseath, G ^a   Lockett, A ^b   Broke Smith, T P ^b   New, R R ^b   Owens, D R ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Isoglycaemic clamp; Oral insulin; Phamacodynamics; Pharmacokinetics; Type 2 diabetes

Indexed keywords

CAPSULIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; NEUTRAL INSULIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DOSE COMPARISON; DRUG SAFETY; DRUG TOLERABILITY; EVENING DOSAGE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; MAXIMUM PLASMA CONCENTRATION; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL; TIME TO MAXIMUM PLASMA CONCENTRATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 73349111300     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01146.x     Document Type: Article

References (16)

1. Joslin EP, Gray H, Root HF. Insulin in hospital and home. J Metab Res 1922, 2:651-699.
2. Gwinup G, Elias N, Domurat ES. Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules. Gen Pharmacol 1991, 22:243-246.
3. Berger M, Berger M, Gries FA. Oral insulin 1922-1992. The history of continuous ambition and failure. Frontiers in Insulin Pharmacology 1993, 144-148. In:, eds., Stuttgart, Georg Thieme Verlag, pp.
4. Carino GP, Jacob JS, Mathiowitz E. Nanosphere based oral insulin delivery. J Contr Release 2000, 65:261-269.
5. Still JG. Development of oral insulin: progress and current status. Diabetes Metab Res Rev 2002, 18((Suppl. 1)):S29-S37.
6. Kipnes M, Dandona P, Triparthy D, Still JG, Kostutic G. Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes. Diabetes Care 2003, 26:421-426.
7. Kidron M, Dihn S, Menachem Y, Abbas R, Variano B, Goldberg M, Arbit E, Bar-On H. A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects. Diabet Med 2004, 21:354-357.
8. Goldberg M, Dinh S, Castelli C, Majuru S, Arbit E. Improved glycemic control with oral recombinant human insulin in patients with type 2 diabetes (T2DM) inadequately controlled on metformin. Diabetes 2007, 56((Suppl. 1)):A121.
9. Suryanarayan S, Khedkar A, Vedala A, Iyer H, Anil K, Desai S, Savale S, Atignal A. Pharmacokinetics and pharmacodynamics of a single oral dose of the insulin analog IN-105, in tablet form, in normal healthy volunteers , in the presence of food. Diabetologia 2007, 50((Suppl. 1)):S95.
10. Carino GP, Mathiowitz E. Oral insulin delivery. Adv Drug Deliv Rev 1999, 35:249-257.
11. Ceflau WT. Concept, strategies, and feasibility of noninvasive insulin delivery. Diabetes Care 2004, 27:239-246.
12. Owens DR. New horizons-alternative routes for insulin therapy. Nat Rev Drug Discov 2002, 1:529-540.
13. Phillips J, Russell-Jones D, Wright J, Brackenridge A, New R, Bansal G. Early evaluation of a novel oral insulin delivery system in healthy volunteers. Diabetes 2004, 53((Suppl. 1)):A113.
14. Whitelaw DC, Kelly CA, Ironmonger W, Cunliffe CM, New R, Phillips JN. Absorption of orally ingested insulin in human type 1 diabetic subjects: Proof of concept study. Diabetes 2005, 54((Suppl. 1)). 5-LB.
15. Luzio S, Dunseath G, Peter R, Pauvaday V, Owens DR. Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes. Diabetologia 2006, 49:1163-1168.
16. A desktop guide to type 2 diabetes mellitus: Diabet Med 1999, 16:716-730. European Diabetes Policy Group